kijimicin

from Actinomadura sp. M1215-NF3; inhibitor of human immunodeficiency virus in acutely & chronically infected cells; structure given in first

Also Known As:

kijimycin; Monensin, 21,25-deepoxy-16-deethyl-25-de(hydroxymethyl)-12-demethyl-21,24-epoxy-25-ethyl-21-hydroxy-8,16-dimethyl-7-O-methyl-, (8R)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Kondoh, Daisuke: 1 article (01/2022)
2.	Leesombun, Arpron: 1 article (01/2022)
3.	Nihei, Coh-Ichi: 1 article (01/2022)
4.	Nishikawa, Yoshifumi: 1 article (01/2022)

1.	Toxoplasmosis 01/01/2022 - "Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice."
2.	Infections 01/01/2022 - "Furthermore, mice treated with kijimicin at 10 mg/kg/day and 3 mg/kg/day showed 91.7% and 66.7% survival rates, respectively, 30 days after infection with T. "

1.	Ionophores